Non-Steroidal Anti-Inflammatory Analgesics Other than Salicylates

Rex N. Brogden

DOI: https://doi.org/10.2165/00003495-198600324-00004

1986-01-01

Drugs

Abstract:The largest group of non-narcotic analgesics are the arylalkanoic acid derivatives, comprising derivatives of arylacetic acid, propionic acid, heteraryl acetic acid and indole acetic acid. Common to all of these drugs is their inhibition of prostaglandin biosynthesis, which contributes to their analgesic and other pharmacological properties as well as to their principal side effect, gastrointestinal irritation. Although these drugs all cause some gastric microbleeding, they do so to a lesser extent than aspirin. The arylalkanoic acid derivatives, as well as the anthranilic acid and oxicam derivatives, are peripherally acting as evidenced by their lack of activity in classical tests of central analgesic activity.After oral administration of these drugs, their peak plasma concentrations are generally attained in 1 to 3 hours; absorption is not generally influenced by food. Volume of distribution is mostly low (less than 0.2 L/kg) and protein binding is high (usually 95 to 99%). Elimination is by glucuronide formation for several of the propionic acid derivatives and generally by biotransformation for derivatives of arylacetic acid, indole and indene acetic acid, and the oxicams. The elimination half-life of the arylalkanoic acid derivatives is in most instances about 2 to 5 hours, although notable exceptions include carprofen (≈ 20h), fenbufen (10h), naproxen (12–15h) and sulindac (16h for the active metabolite). The elimination half-life of indomethacin varies considerably between and within individuals. Piroxicam has the longest half-life, averaging 45 hours. The pharmacokinetic properties of the anthranilic acid derivatives (fenamates, glafenine) generally resemble those of the arylacetic acids.Few clinically significant drug interactions are associated with concomitant administration of the arylalkanoic acids or piroxicam and other drugs. Since the arylalkanoic acids are highly bound to plasma proteins (mainly albumin) there is a theoretical potential for displacement reactions with drugs that are used at plasma concentrations high enough to exceed the binding capacity of their own primary binding sites. However, such reactions have rarely been reported. Although the concomitant administration of aspirin and several of the propionic acid derivatives results in a significant decrease in the plasma concentration of the latter, the clinical significance of such interactions is uncertain and probably minimal. Acenocoumarol has been reported to interact with several propionic acid derivatives and with piroxicam with a consequent increase in anticoagulant effects, thus indicating the need for caution in patients receiving these drugs concomitantly. They may also increase the risk of gastrointestinal bleeding. Indomethacin has been implicated in drug interactions more frequently than other arylalkanoic acid derivatives. All these drugs cause sodium and fluid retention and antagonise the effects of diuretics and drugs used in the treatment of hypertension.The analgesic efficacy of the arylalkanoic acid derivatives has been studied in patients with pain of varying aetiology. Since the ability of drugs to alleviate pain is best studied in models where pain is fairly intense and quantifiable, discussion in this paper of the analgesic efficacy of these drugs is confined to single-dose studies in dental and other postsurgical pain that have been conducted double-blind and included a placebo control group. Under these conditions, the propionic acid and other arylalkanoic acid derivatives have been shown to be more effective than aspirin. The arylalkanoic acid derivatives have also generally been found to be more effective analgesics than dextropropoxyphene and codeine phosphate. Fenoprofen, indoprofen and naproxen at usual dosages have been shown to be comparable with morphine sulphate 5 to 10mg in relieving postoperative pain. The most common side effects are gastrointestinal, although severe cutaneous reactions, hepato-renal damage and, in the case of zomepirac, anaphylactoid reactions have resulted in the withdrawal of alclofenac, fenclofenac, indoprofen, feprazone, zomepirac and benoxaprofen from the market.

pharmacology & pharmacy,toxicology